甲状腺毒症合并心房颤动时的动脉栓塞
Arterial embolism in thyrotoxicosis with atrial fibrillation.
作者信息
Staffurth J S, Gibberd M C, Fui S N
出版信息
Br Med J. 1977 Sep 10;2(6088):688-90. doi: 10.1136/bmj.2.6088.688.
Abstract
In 262 patients with thyrotoxicosis and atrial fibrillation there were 26 episodes of arterial embolism (17 cerebral and nine elsewhere) in 21 patients. Twelve incidents occurred with active thyrotoxicosis, three on reversion to sinus rhythm, and 11 after the patients were euthyroid. This important complication is more common than is realised, and most patients should be put on prophylactic anticoagulants when first seen with atrial fibrillation.
摘要
在262例甲状腺毒症合并心房颤动的患者中，21例患者发生了26次动脉栓塞事件（17次脑部栓塞，9次其他部位栓塞）。12次事件发生在甲状腺毒症活动期，3次发生在恢复窦性心律时，11次发生在患者甲状腺功能正常后。这种重要的并发症比人们意识到的更为常见，大多数患者首次出现心房颤动时就应接受预防性抗凝治疗。
相似文献
1
Arterial embolism in thyrotoxicosis with atrial fibrillation.甲状腺毒症合并心房颤动时的动脉栓塞
Br Med J. 1977 Sep 10;2(6088):688-90. doi: 10.1136/bmj.2.6088.688.
2
Occult thyrotoxicosis in patients with atrial fibrillation and an acute arterial embolism.
Angiology. 1988 Nov;39(11):981-5. doi: 10.1177/000331978803901108.
3
[Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis].
Ugeskr Laeger. 1995 Jul 17;157(29):4138-9.
4
Atrial fibrillation and arterial embolism in hyperthyroidism.甲状腺功能亢进症中的心房颤动和动脉栓塞
Aust N Z J Med. 1981 Aug;11(4):391-3. doi: 10.1111/j.1445-5994.1981.tb03519.x.
5
Embolism in thyrotoxic atrial fibrillation.甲状腺毒症性心房颤动中的栓塞
Med J Aust. 1979 Jun 30;1(13):630-1. doi: 10.5694/j.1326-5377.1979.tb119428.x.
6
Arterial embolism in thyrotoxicosis with atrial fibrillation.甲状腺毒症伴心房颤动时的动脉栓塞
Arch Intern Med. 1981 Aug;141(9):1191-2.
7
Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.
Am J Cardiol. 1979 Jul;44(1):9-12. doi: 10.1016/0002-9149(79)90243-1.
8
Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.甲状腺功能亢进引起的心房颤动的栓塞风险：医学文献综述
Tex Heart Inst J. 2011;38(3):225-8.
9
Acute exacerbation of masked hyperthyroidism after iodine restriction followed by thyrotoxic atrial fibrillation and cerebral embolism. A case report.碘限制后隐匿性甲状腺功能亢进急性加重，继以甲状腺毒症性心房颤动和脑栓塞。一例报告。
Angiology. 1996 Jul;47(7):709-12. doi: 10.1177/000331979604700712.
10
Significance of atrial fibrillation as a precursor of embolism.心房颤动作为栓塞先兆的意义。
Am J Cardiol. 1989 Jun 1;63(18):1405-7. doi: 10.1016/0002-9149(89)91058-8.
引用本文的文献
1
Atrial Fibrillation and Associated Factors Among Hyperthyroidism Patients Attending at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.埃塞俄比亚西北部贡德尔大学综合专科医院甲状腺功能亢进患者的心房颤动及相关因素
Clin Med Insights Endocrinol Diabetes. 2024 Sep 30;17:11795514241285347. doi: 10.1177/11795514241285347. eCollection 2024.
2
The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis.甲状腺功能亢进对凝血及血栓形成风险的影响。
J Clin Med. 2024 Mar 19;13(6):1756. doi: 10.3390/jcm13061756.
3
The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation.甲状腺功能亢进所致心房颤动的电复律结果
Cureus. 2023 Apr 21;15(4):e37928. doi: 10.7759/cureus.37928. eCollection 2023 Apr.
4
Effect of Hyperthyroidism Treatments on Heart Rate Variability: A Systematic Review and Meta-Analysis.甲状腺功能亢进症治疗对心率变异性的影响：一项系统评价和荟萃分析。
Biomedicines. 2022 Aug 16;10(8):1982. doi: 10.3390/biomedicines10081982.
5
Cardiovascular Manifestations in Hyperthyroidism: A Cross-Sectional Study in a Tertiary Care Hospital in South India.甲状腺功能亢进症的心血管表现：印度南部一家三级护理医院的横断面研究。
Cureus. 2022 May 23;14(5):e25232. doi: 10.7759/cureus.25232. eCollection 2022 May.
6
Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review.甲状腺功能亢进症与心律失常风险：一篇叙述性综述。
Cureus. 2022 Apr 22;14(4):e24378. doi: 10.7759/cureus.24378. eCollection 2022 Apr.
7
Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis.抗凝治疗在甲状腺毒症性心房颤动中的疗效与安全性：一项系统评价与荟萃分析。
Endocr Connect. 2022 May 23;11(5):e220166. doi: 10.1530/EC-22-0166.
8
Hemodynamic variation is a dominant contributing factor of Graves' hyperthyroidism complication: Heart failure and fatal liver dysfunction, a case report and analysis.血流动力学变化是格雷夫斯甲亢并发症（心力衰竭和致命性肝功能障碍）的主要促成因素：病例报告与分析
Clin Case Rep. 2022 Feb 3;10(2):e05289. doi: 10.1002/ccr3.5289. eCollection 2022 Feb.
9
Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery.左甲状腺素治疗与心律失常风险 - 关注接受甲状腺手术的患者。
Front Endocrinol (Lausanne). 2021 Nov 4;12:758043. doi: 10.3389/fendo.2021.758043. eCollection 2021.
10
Hyperthyroidism With Atrial Fibrillation in Children: A Case Report and Review of the Literature.儿童甲状腺功能亢进伴心房颤动：病例报告及文献复习。
Front Endocrinol (Lausanne). 2021 Sep 20;12:689497. doi: 10.3389/fendo.2021.689497. eCollection 2021.
本文引用的文献
1
Vital Statistics.人口动态统计。
Br Med J. 1959 Jan 24;1(5116):244-5.
2
Auricular fibrillation in thyrotoxicosis, with special regard to the indication for quinidine therapy.
Acta Med Scand Suppl. 1952;266:585-93. doi: 10.1111/j.0954-6820.1952.tb13408.x.
3
Responses to radioactive iodine therapy in hyperthyroidism, with special reference to cardiac problems.甲状腺功能亢进症对放射性碘治疗的反应，特别提及心脏问题。
J Clin Endocrinol Metab. 1951 Nov;11(11):1296-1322. doi: 10.1210/jcem-11-11-1296.
4
5
RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES.甲状腺毒症的放射性碘治疗；908例病例综述。
Scott Med J. 1964 Dec;9:505-13. doi: 10.1177/003693306400901201.
6
The treatment of thyrocardiac disease with radioactive iodine.放射性碘治疗甲状腺心脏病
Prog Cardiovasc Dis. 1962 Jul;5:64-80. doi: 10.1016/s0033-0620(62)80005-x.
7
An appreciation of mitral stenosis. I. Clinical features.二尖瓣狭窄的认识。I. 临床特征。
Br Med J. 1954 May 8;1(4870):1051-63; contd. doi: 10.1136/bmj.1.4870.1051.
8
Atrial fibrillation in thyrotoxicosis treated with radioiodine.放射性碘治疗甲状腺毒症所致心房颤动
Postgrad Med J. 1965 Nov;41(481):663-71. doi: 10.1136/pgmj.41.481.663.
9
Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up.电复律治疗房性心律失常的预后。三年随访。
Br Heart J. 1969 Jul;31(4):496-500. doi: 10.1136/hrt.31.4.496.
10
Prognosis of cerebral embolism.脑栓塞的预后。
Lancet. 1965 Sep 11;2(7411):514-9. doi: 10.1016/s0140-6736(65)91473-x.
Zotero 插件